A Study of ST-1898 for Unresectable or Metastatic Melanoma
Clinical trial NCT06359860 · RECRUITING
Trial details
- NCT number
- NCT06359860
- Sponsor
- Beijing Scitech-Mq Pharmaceuticals Limited
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2026-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.